Closed System Transfer Devices (Membrane-to-Membrane, Needleless) Market - Global Forecast to 2026 - ResearchAndMarkets.com
Retrieved on:
Tuesday, October 12, 2021
Biotechnology, Medical Devices, Health, Pharmaceutical, Oncology, Transfer, Physical Sciences-Oncology Centers, Incidence, Efficiency, Risk, USD, Oncology, Compartmentalization, Atmosphere, Baxter International, CAGR, CSTD, Nursing, ICU Medical, Growth, Safety, Cancer, Clifton Springs Hospital & Clinic, Pressure, Adoption, Prevalence, Hospital, Luer, Component, Becton, Dickinson and Company headquarters, Needleless connector, Region, Becton, JMS, Diaphragm, Pharmacist, Pet, Healthcare
The closed system transfer devices (CSTDs) market is projected to reach USD 2,002 million by 2026 from USD 814 million in 2021, at a CAGR of 19.7%.
Key Points:
- The closed system transfer devices (CSTDs) market is projected to reach USD 2,002 million by 2026 from USD 814 million in 2021, at a CAGR of 19.7%.
- The diaphragm-based devices segment accounted for the largest share of the closed system transfer devices market in 2020.
- The vial access devices segment accounted for the largest share of the closed system transfer devices market in 2020.
- Major players in the closed system transfer devices market include Becton, Dickinson and Company (US), ICU Medical (US), Equashield.